tiprankstipranks
Trending News
More News >
Lantern Pharma, Inc. (LTRN)
:LTRN
US Market

Lantern Pharma (LTRN) Technical Analysis

Compare
268 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
4Neutral
11Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Lantern Pharma, Inc.’s (LTRN) Moving Averages Convergence Divergence (MACD) indicator is -0.09, suggesting Lantern Pharma, Inc. is a Sell.
Lantern Pharma, Inc.’s (LTRN) 20-Day exponential moving average is 3.37, while Lantern Pharma, Inc.’s (LTRN) share price is $3.32, making it a Buy.
Lantern Pharma, Inc.’s (LTRN) 50-Day exponential moving average is 3.50, while Lantern Pharma, Inc.’s (LTRN) share price is $3.32, making it a Sell.

Lantern Pharma (LTRN) Pivot Points

Jun 11, 2025, 03:41 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.06
3.15
3.24
3.33
3.42
3.51
3.60
Fibonacci
3.15
3.22
3.26
3.33
3.40
3.44
3.51
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Lantern Pharma (LTRN) Moving Averages

Jun 11, 2025, 03:41 AM
Period
Simple
Exponential
MA5
3.34Buy
3.32Buy
MA10
3.18Buy
3.30Buy
MA20
3.42Sell
3.37Buy
MA50
3.43Sell
3.50Sell
MA100
3.83Sell
3.64Sell
MA200
3.71Sell
3.75Sell
Lantern Pharma, Inc.’s (LTRN) 10-Day exponential moving average is 3.30, while Lantern Pharma, Inc.’s (LTRN) share price is $3.32, making it a Buy.
Lantern Pharma, Inc.’s (LTRN) 100-Day exponential moving average is 3.64, while Lantern Pharma, Inc.’s (LTRN) share price is $3.32, making it a Sell.
Lantern Pharma, Inc.’s (LTRN) stock price is $3.32 and Lantern Pharma, Inc.’s (LTRN) 50-day simple moving average is 3.43, creating a Sell signal.
Lantern Pharma, Inc.’s (LTRN) stock price is $3.32 and Lantern Pharma, Inc.’s (LTRN) 100-day simple moving average is 3.83, creating a Sell signal.
Lantern Pharma, Inc.’s (LTRN) stock price is $3.32 and Lantern Pharma, Inc.’s (LTRN) 200-day simple moving average is 3.71, creating a Sell signal.

Lantern Pharma (LTRN) Technical Indicators

Jun 11, 2025, 03:41 AM
Name
Value
Implied Action
RSI (14)
49.04
Neutral
STOCH (9,6)
82.94
Sell
STOCHRSI (14)
58.47
Neutral
MACD (12,26)
-0.09
Sell
ADX (14)
19.93
Buy
Williams %R
-36.59
Buy
CCI (14)
-21.17
Neutral
ATR (14)
0.28
-
Ultimate Oscillator
59.35
Neutral
ROC
-5.87
Sell
Lantern Pharma, Inc.’s (LTRN) Relative Strength Index (RSI) is 49.04, creating a Neutral signal.
Lantern Pharma, Inc.’s (LTRN) Trend Strength Indicator (ADX) is 19.93, creating a Buy signal.
Lantern Pharma, Inc.’s (LTRN) Commodity Channel Index (CCI) is -21.17, creating a Neutral signal.
Lantern Pharma, Inc.’s (LTRN) Price Rate of Change (ROC) is -5.87, creating a Sell signal.

FAQ

Is LTRN a Buy, Hold, or Sell?
Based on LTRN’s technical indicators, LTRN is a Sell.
    What is LTRN’s RSI (14)?
    LTRN’s RSI (14) is 49.04, which suggests LTRN is a Neutral.
      What is LTRN’s MACD?
      LTRN’s MACD is -0.09, which suggests LTRN is a Sell.
        What is LTRN’s 5-day moving average?
        LTRN’s 5-day moving average is 3.34, which suggests LTRN is a Buy.
          What is LTRN’s 20-day moving average?
          LTRN 20-day moving average is 3.42, which suggests LTRN is a Sell.
            What is LTRN’s 50-day moving average?
            LTRN’s 50-day moving average is 3.43, which suggests LTRN is a Sell.
              What is LTRN’s 200-day moving average?
              LTRN’s 200-day moving average is 3.71, which suggests LTRN is a Sell.
                What is LTRN’s Williams % R (14)?
                LTRN’s Williams % R (14) is -36.59, which suggests LTRN is a Buy.
                  What is LTRN’s CCI (14)?
                  LTRN’s CCI (14) is -21.17, which suggests LTRN is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis